Supported by

Renal denervation

Here you will find all the latest content on renal denervation published on this website. Results are listed in chronological order.

Despite the existence of effective antihypertensive drugs, arterial hypertension remains a critical challenge for healthcare systems worldwide. Can catheter-based renal denervation play an effective part in reducing, previously untreatable high blood pressure? Follow the latest research in this novel field along with the critical issues of blood pressure monitoring, imaging modalities, tools, devices and techniques as well as vascular access, bleeding risk and adjunctive pharmacotherapy…

Filtered By
Renal denervation

80 results

Renal denervation and uncontrolled hypertension – evolving data

06 Sep 2017

Can renal denervation have a positive effect on controlling blood pressure? F. Mahfoud reports from the ESC Congress 2017 in Barcelona as he introduces a late breaking trial which answers in the affirmative. Three-month results of the international SPYRAL HTN-OFF MED study demonstrated a “significant reduction in ambulatory and office blood pressure” in the denervation arm. Learning from earlier trials, discover how this new study could provide sound biological proof of principal, underlining the evolution in our understanding of anatomy and particularly in our approach to the technique itself. What does the future hold? What type of patient responds best? Find out more here…

EuroPCR 2017 Highlights: Interventions for Hypertension

23 May 2017 - From EUROPCR 2017

What’s happening in the field of the device-based treatment of hypertension? Join S. Ewen, F. Mahfoud and A. Pathak as they review the different sessions at EuroPCR 2017 dedicated to this challenging topic. Explore exciting new devices such as one aimed at the carotid region using baroreflex activation, which might have an effect on heart failure as well as resistant hypertension. Look at a new transcatheter approach to modulate the carotid body.  Learn about current data and results in the ongoing trials in renal denervation. Watch here...

Clinical Research Forum on device-based therapies for hypertension – Update from the Clinical Consensus Conference on Device-based Hypertension Therapies

18 May 2017 – From EuroPCR 2017

Consult this session Clinical Research Forum on device-based therapies for hypertension with the collaboration of the Practical Course on Hypertension (PCH) if you want to find out more about patient recruitment for clinical trials, patient communication strategies and specific features of devices for hypertension treatment.

Device-based interventional therapies for hypertension – Part II – Catheter-based renal denervation

18 May 2017 – From EuroPCR 2017

Consult this session on Device-based interventional therapies for hypertension – Part II: Catheter-based renal denervation if you want to learn more about treatment recommendations of renal denervation systems.

With the collaboration of the Practical Course on Hypertension (PCH).

Renal denervation for hypertension: path ahead and what to expect from the ongoing clinical studies

18 May 2017 – From EuroPCR 2017

Resurrecting renal denervation: optimising the procedure

17 May 2017 – From EuroPCR 2017

Consult this session from EuroPCR 2017 on resurrecting renal denervation: optimising the procedure and discover the presentation by F. Ribichini on a patient with severe hypertension on multiple medications with branch treatment.

Renal interventions for resistant hypertension

17 May 2017 – From EuroPCR 2017

John Ormiston awarded the EuroPCR 2017 Ethica Award

16 May 2017

The 2017 Ethica Award, the highest honour of the European cardiovascular intervention academies, was presented to John Ormiston, New Zealand’s most experienced interventional cardiologist. The Ethica Award celebrates people who have made an outstanding contribution to interventional patient care.

Novel insights from renal denervation studies

16 May 2017 – From EuroPCR 2017

2017 Ethica Award

16 May 2017 – From EuroPCR 2017

The 2017 Ethica Award, the highest honour of the European cardiovascular intervention academies celebrates people who have made an outstanding contribution to interventional patient care. Join H. Amin and J. Fajadet who will present this year's Ethica Award ceremony during EuroPCR 2017.